In a pivotal early study, Kortylewski et al. demonstrated that hematopoietic cell-specific inhibition of STAT3 in tumor-bearing mice led to significantly enhanced functional activity of T, NK, and dendritic cells, resulting in antitumor immunity and growth inhibition [92]. This evidence concerns the gene STAT3 and neoplasm.